Clovis Oncology Inc. (NASDAQ: CLVS) started the day on May 19, 2021, with a price decrease of -4.01% at $5.27. During the day, the stock rose to $5.515 and sunk to $5.24 before settling in for the price of $5.49 at the close. Taking a more long-term approach, CLVS posted a 52-week range of $4.08-$11.10.
Meanwhile, its Annual Earning per share during the time was 14.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 41.10%. This publicly-traded company’s shares outstanding now amounts to $104.25 million, simultaneously with a float of $86.43 million. The organization now has a market capitalization sitting at $527.63 million. At the time of writing, stock’s 50-day Moving Average stood at $6.13, while the 200-day Moving Average is $5.87.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 429 employees. It has generated 383,501 per worker during the last fiscal year. Meanwhile, its income per employee was -860,634. The stock had 5.04 Receivables turnover and 0.26 Total Asset turnover. For the Profitability, stocks gross margin was +74.89, operating margin was -183.68 and Pretax Margin of -224.75.
Clovis Oncology Inc. (CLVS) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Clovis Oncology Inc.’s current insider ownership accounts for 0.40%, in contrast to 52.10% institutional ownership. According to the most recent insider trade that took place on May 04, this organization’s See Remarks sold 3,952 shares at the rate of 5.54, making the entire transaction reach 21,894 in total value, affecting insider ownership by 247,059. Preceding that transaction, on May 04, Company’s See Remarks sold 4,837 for 5.54, making the whole transaction’s value amount to 26,797. This particular insider is now the holder of 52,008 in total.
Clovis Oncology Inc. (CLVS) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 3/30/2021, the organization reported -$0.64 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.72) by $0.08. This company achieved a net margin of -224.41. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.53 per share during the current fiscal year.
Clovis Oncology Inc.’s EPS increase for this current 12-month fiscal period is 41.10% and is forecasted to reach -1.21 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 63.10% through the next 5 years, which can be compared against the 14.90% growth it accomplished over the previous five years trading on the market.
Clovis Oncology Inc. (NASDAQ: CLVS) Trading Performance Indicators
Let’s observe the current performance indicators for Clovis Oncology Inc. (CLVS). It’s Quick Ratio in the last reported quarter now stands at 1.30. The Stock has managed to achieve an average true range (ATR) of 0.40. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.21.
In the same vein, CLVS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.45, a figure that is expected to reach -0.55 in the next quarter, and analysts are predicting that it will be -1.21 at the market close of one year from today.
Technical Analysis of Clovis Oncology Inc. (CLVS)
If we take a close look at the recent performances of Clovis Oncology Inc. (NASDAQ: CLVS), its last 5-days Average volume was 3.46 million that shows plunge from its year to date volume of 10.55 million. During the previous 9 days, stock’s Stochastic %D was recorded 43.51% While, its Average True Range was 0.41.
Raw Stochastic average of Clovis Oncology Inc. (CLVS) in the period of the previous 100 days is set at 12.86%, which indicates a major fall in contrast to 18.05% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 64.00% that was lower than 108.80% volatility it exhibited in the past 100-days period.